Precirol ATO 5

Product Description
Gattefosse S.A.

-
FR
-
2015On CPHI since
Company types
Categories
Gattefosse S.A.

-
FR
-
2015On CPHI since
Company types
More Products from Gattefosse S.A. (46)
-
Product Monosteol
Monosteol™ is a lipidic vehicle used as consistency agent in topical formulations. Enhances stability by preventing phase separation and oil droplet coalescence. -
Product Ovucire 3460
Ovucire® 3460 is a hard fat pessary base delivering enhanced spreadability within the vaginal cavity and good mechanical resistance. Non-irritant providing excellent mucosal tolerance.
-
Product Ovucire WL 3264
Ovucire® WL 3264 is a hard fat pessary base with emulsifier to improve dispersibility and wettability of hydrophobic APIs. -
Product Peceol
Peceol™ is a an oily vehicle used as solubilizer for lipophilic APIs in oral and topical formulations.
-
Product Plurol Diisostearique
Plurol® Diisostearique is a nonionic water-in-oil emulsifier for topical emulsions. A PEG-free liquid emulsifier ideal for cold formulation processes with heat sensitive APIs.
-
Product Plurol Oleique CC 497
Plurol® Oleique CC 497 (Polyglyceryl-3 dioleate) is a a nonionic water-insoluble surfactant used as cosurfactant in oral lipid-based formulation SEDDS and SMEDDS. Cosurfactant and solubilizer in topical dosage forms.
-
Product Sedefos 75
Gattefosse S.A offers a wide range of products which includes Sedefos™ 75. It belongs to emulsifiers category. It is recommended for anhydrous emulsions for hydrosensitive actives requiring PEGs or glycerine as hydrophilic phase, emulsions containing a high concentration of alcohol or oily phase, acidic ac... -
Product Suppocire AGP Pellets
Suppocire® AGP Pellets is hard fat suppository base with emulsifier to improve dispersion of hydrophilic APIs, recommended for formulation of glycerin suppositories. -
Product Suppocire AM Pellets
Suppocire® AM Pellets is a hard fat suppository base that provides excellent chemical stability with acidic APIs and high crystallization rate.
A versatile base with precedence of use with a wide range of APIs.
-
Product Suppocire AP Pellets
Suppocire® AP Pellets is hard fat suppository base comprising polyoxylglyceride esters to enhance drug solubility and bioavailability.
-
Product Suppocire AS2 Pellets
Suppocire® AS2 Pellets is a hard fat suppository base with modified monoglyceride content recommended for hydrophilic APIs requiring fast release.
-
Product Suppocire BM Pellets
Suppocire® BM Pellets is a hard fat suppository base with excellent chemical compatibility and high crystallization rate. A versatile base with precedence of use with a wide range of APIs.
Gattefosse S.A. resources (7)
-
News Gelucire® 59/14, solid surfactant for oral bioavailability enhancement
Discover Gelucire® 59/14, an add-on in Gattefossé Gelucire® range, for oral bioavailability enhancement -
News Boost your drug bioavailability with Labrafac™ MC60
Discover Labrafac™ MC60, glycerol monocaprylocaprate, an oral bioavailability enhancer.
-
Video Emulfree® Duo, for bi-gels: An Innovative Texture
This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Patient adherence to skin treatments Bi-gels: formulating new topical drugs Emulfree® Duo, a ready-to-use excipient designed to make bi-gels Case studies -
News Innovate in bi-gel with Emulfree® Duo
Discover our brand new excipient Emulfree® Duo, a ready-to-use stabilizing agent, enabler of bi-gel, an emerging topical dosage form.
-
Video Boost your Drug Bioavailability with Labrafac™ MC60, Glycerol Monocaprylocaprate
This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. This session explores: Using Lipid-based formulations to address oral bioavailability issues Labrafac™ MC60, glycerol monocaprylocaprate, Gattefossé new bioehancer Case study: step-by-step development of a lipid-based formulation of dutasteride with Labrafac™ MC60 Gattefossé technical expertise -
News Lipid-based formulations: winning strategy for oral bioavailability enhancement
Many drugs exhibit poor solubility and/or permeability leading to weak oral bioavailability. To overcome these issues, different technologies have been developed. Among them, lipid-based formulation (LBF) is an option worth considering as it can be used from the very beginning of drug development to product, reducing time to market.
Frequently Viewed Together
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance